Skip to main content

Advertisement

Log in

Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany

  • ORIGINAL PAPER
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Summary

Aims

The DETECT study was performed to obtain representative data about the frequency, distribution, and treatment of patients with coronary artery disease (CAD) in the primary care setting in Germany.

Methods and results

The DETECT study was a cross–sectional clinical– epidemiological survey of a nationally representative sample of 3795 primary care offices and 55 518 patients. Overall, 12.4% of patients were diagnosed with CAD. Stable angina pectoris and myocardial infarction were the most frequent (4.2%) subgroups, followed by status post (s/p) percutaneous coronary interventions (PCI, 3.0%) and s/p coronary bypass surgery (2.2%). Patients with CAD were prescribed AT1 receptor antagonists (in 19.4% of cases), beta blockers (57.2%), ACE inhibitors (49.9%), antiplatelet agents (52.7%), statins (43.0%), and long–term nitrates (24.5%). When comparing all CAD patients with social health care insurance to those who had private insurance, private patients had significantly higher rates of revascularisation procedures and use of preventive medications.

Conclusion

Great potential remains for improving secondary prevention in primary care in Germany to reduce the risk of further coronary or vascular events, especially in patients with social health care insurance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. De Backer G, Ambrosioni E, Borch– Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth–Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D (2003) Executive Summary: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (executive summary). Eur Heart J 24:1601–1610

    Article  PubMed  Google Scholar 

  2. Koenig W (1998) Epidemiology of coronary heart disease. Z Kardiol 87 (Suppl 2):3–7

    Article  PubMed  Google Scholar 

  3. Statistisches Bundesamt Deutschland (2005) http://www.destatis.de

  4. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26:804–847

    Article  PubMed  Google Scholar 

  5. Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W (2005) Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J 26:1169– 1179

    Article  PubMed  CAS  Google Scholar 

  6. Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KM (2005) The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 26:1011–1022

    Article  PubMed  Google Scholar 

  7. Wittchen HU, Glaesmer H, März W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Böhler S, Pittrow D, Ruf G (2005) Cardiovascular risk factors in primary care: methods and baseline prevalence rates – the DETECT program. Curr Med Res Opin 21:619–630

    Article  PubMed  Google Scholar 

  8. Böhler S, Glaesmer H, Pittrow D, Lehnert H, Stalla GK, Zeiher AM, März W, Silber S, Wehling M, Ruf G, Reinecke A, Wittchen HU (2004) Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues – rationale for a nationwide primary care project in Germany. Exp Clin Endocrinol Diabetes 112:157–170

    Article  PubMed  Google Scholar 

  9. StataCorp., Stata Statistical Software, Release 8.0 (2003) College Station, TX: Stata Corporation

  10. Knopf H (2004) Arzneimittelanwendung bei Frauen und Männern mit koronarer Herzkrankheit. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 47:1051–1056

    Article  CAS  Google Scholar 

  11. Equinox Group (2001) Stable Angina Epidemiology. Equinox Drug Assessment Library

  12. Jaber WA, Lennon RJ, Mathew V, Holmes DR Jr, Lerman A, Rihal CS (2005) Application of evidence–based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator. J Am Coll Cardiol 46:1473–1478

    Article  PubMed  Google Scholar 

  13. Silber S, Krischke I, Prohaska M (2000) Undertreatment in secondary prevention of patients with coronary heart disease after revascularization. Herz 25:623–626

    Article  PubMed  CAS  Google Scholar 

  14. The EUROASPIRE I and II Group (2001) Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 357:995–1001

    Article  Google Scholar 

  15. Brady AJB, Oliver MA, Pittard JB (2001) Secondary prevention in 24 431 patients with coronary heart disease: survey in primary care. BMJ 322:1463

    Article  PubMed  CAS  Google Scholar 

  16. Abuful A, Gidron Y, Henkin Y (2005) Physician’s attitudes toward preventive therapy for coronary artery disease: Is there a gender bias? Clinical Cardiology 28(8):389–393

    PubMed  Google Scholar 

  17. Hippisley–Cox J, Pringle M, Crown N, Meal A, Wynn A (2001) Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 322:832

    Article  PubMed  CAS  Google Scholar 

  18. Sheifer SE, Escarce JJ, Schulman KA (2000) Race and sex differences in the management of coronary artery disease. American Heart Journal 139(5):848–857

    Article  PubMed  CAS  Google Scholar 

  19. Schwartz JB (2003) Gender–specific implications for cardiovascular medication use in the elderly optimizing therapy for older women. Cardiol Rev 11:275–298

    Article  PubMed  Google Scholar 

  20. Os I, Bratland B, Dahlhof B, Gisholt K, Syvertsen JO, Tretli S (1994) Female preponderance for lisinopril–induced cough in hypertension. Am J Hypertens 7(11):1012–1015

    PubMed  CAS  Google Scholar 

  21. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, Brogan GXJ, Boden WE, Roe MT, Ohman EM, Gibler WB, Newby LK, CRUSADE I (2005) Gender disparities in the diagnosis and treatment of non–ST–segment elevation acute coronary syndromes: large–scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/ American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 45(6):832–837

    Article  PubMed  Google Scholar 

  22. Doyle F, De La Harpe D, McGee H, Shelley E, Conroy R (2005) Gender differences in the presentation and management of acute coronary syndromes: a national sample of 1365 admissions. Eur J Cardiovasc Prev Rehabil 12(4):376–379

    Article  PubMed  Google Scholar 

  23. Heer T, Schiele R, Schneider S, Gitt AK, Wienbergen H, Gottwik M, Gieseler U, Voigtlander T, Hauptmann KE, Wagner S, Senges J (2002) Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol 89(5):511–517

    Article  PubMed  Google Scholar 

  24. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dubé R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ, Ayers W (1999) The effect of race and sex on physicians’ recommendations for cardiac catheterization. N Engl J Med 25; 340(8):618–626

    Article  CAS  Google Scholar 

  25. Bertoni AG, Bonds DE, Lovato J, Goff DC, Brancati FL (2004) Sex disparities in procedure use for acute myocardial infarction in the United States, 1995 to 2001. Am Heart J 147(6):1054–1060

    Article  PubMed  Google Scholar 

  26. Yu BR (2005) Influences of health insurance status on clinical treatments and outcomes for 4714 patients after acute myocardial infarction in 14 Chinese general hospitals. J Med Dent Sci 52(2):143–151

    PubMed  Google Scholar 

  27. Hiestand BC, Prall DM, Lindsell CJ, Hoekstra JW, Pollack CV, Hollander JE, Tiffany BR, Peacock WF, Diercks DB, Gibler WB (2004) Insurance status and the treatment of myocardial infarction at academic centers. Acad Emerg Med 11(4):343–348

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Sigmund Silber.

Additional information

DETECT, Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment (See appendix)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bischoff, B., Silber, S., Richartz, B.M. et al. Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany. Clin Res Cardiol 95, 405–412 (2006). https://doi.org/10.1007/s00392-006-0399-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-006-0399-2

Key words

Navigation